Evidence map›Paper›PMID 37221951›Full record

ArticleJournal of the International AIDS Society2023

Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance Network.

Machiko Otani, Teiichiro Shiino, Atsuko Hachiya, Hiroyuki Gatanaga, Dai Watanabe, Rumi Minami, Masako Nishizawa, Takanori Teshima, Shigeru Yoshida, Toshihiro Ito and 29 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Machiko OtaniAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-2978-0712
Teiichiro ShiinoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Atsuko HachiyaClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Hiroyuki GatanagaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Dai WatanabeAIDS Medical Center, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Rumi MinamiInternal Medicine, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Masako NishizawaAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Takanori TeshimaDepartment of Clinical Laboratories, Hokkaido University Hospital, Hokkaido, Japan.
Shigeru YoshidaSchool of Medical Technology, Health Sciences University of Hokkaido, Hokkaido, Japan.
Toshihiro ItoDepartment of Infectious Diseases, National Hospital Organization Sendai Medical Center, Miyagi, Japan.
Tsunefusa HayashidaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Michiko KogaInstitute of Medical Science, University of Tokyo, Tokyo, Japan.
Mami NagashimaTokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Kenji SadamasuTokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Makiko KondoDivision of Microbiology, Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan.
Shingo KatoDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Shunsuke UnoDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Toshibumi TaniguchiDepartment of Infection Control, Chiba University Hospital, Chiba, Japan.
Hidetoshi IgariDepartment of Infection Control, Chiba University Hospital, Chiba, Japan.
Sei SamukawaDepartment of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan.
Hideaki NakajimaDepartment of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan.
Yusuke YoshinoDepartment of Microbiology, Teikyo University School of Medicine, Tokyo, Japan.
Masahide HoribaDepartment of Respiratory Medicine, National Hospital Organization Higashisaitama National Hospital, Saitama, Japan.
Hiroshi MoroDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Tamayo WatanabeDepartment of Immunology and Infectious Disease, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Mayumi ImahashiClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Yoshiyuki YokomakuClinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
Haruyo MoriDivision of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
Teruhisa FujiiDivision of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Kiyonori TakadaPostgraduate Clinical Training Center, Ehime University Hospital, Ehime, Japan.
Asako NakamuraDivision of Virology, Fukuoka Institute of Health and Environmental Sciences, Fukuoka, Japan.
Hideta NakamuraDepartment of Infectious, Respiratory, and Digestive Medicine, Control and Prevention of Infectious Diseases, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Masao TateyamaDepartment of Infectious, Respiratory, and Digestive Medicine, Control and Prevention of Infectious Diseases, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Shuzo MatsushitaJoint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Kazuhisa YoshimuraTokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Wataru SugiuraCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Tetsuro MatanoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0003-3096-6749
Tadashi KikuchiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Japanese Drug Resistance HIV-1 Surveillance Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLate diagnosis of the human immunodeficiency virus (HIV) is a major concern epidemiologically, socially and for national healthcare systems. Although the association of certain demographics with late HIV diagnosis has been reported in several studies, the association of other factors, including clinical and phylogenetic factors, remains unclear. In the present study, we conducted a nationwide analysis to explore the association of demographics, clinical factors, HIV-1 subtypes/circulating recombinant form (CRFs) and genetic clustering with late HIV diagnosis in Japan, where new infections mainly occur among young men who have sex with men (MSM) in urban areas.

methodsAnonymized data on demographics, clinical factors and HIV genetic sequences from 39.8% of people newly diagnosed with HIV in Japan were collected by the Japanese Drug Resistance HIV-1 Surveillance Network from 2003 to 2019. Factors associated with late HIV diagnosis (defined as HIV diagnosis with a CD4 count <350 cells/μl) were identified using logistic regression. Clusters were identified by HIV-TRACE with a genetic distance threshold of 1.5%.

resultsOf the 9422 people newly diagnosed with HIV enrolled in the surveillance network between 2003 and 2019, 7752 individuals with available CD4 count at diagnosis were included. Late HIV diagnosis was observed in 5522 (71.2%) participants. The overall median CD4 count at diagnosis was 221 (IQR: 62-373) cells/μl. Variables independently associated with late HIV diagnosis included age (adjusted odds ratio [aOR] 2.21, 95% CI 1.88-2.59, ≥45 vs. ≤29 years), heterosexual transmission (aOR 1.34, 95% CI 1.11-1.62, vs. MSM), living outside of Tokyo (aOR 1.18, 95% CI 1.05-1.32), hepatitis C virus (HCV) co-infection (aOR 1.42, 95% CI 1.01-1.98) and not belonging to a cluster (aOR 1.30, 95% CI 1.12-1.51). CRF07_BC (aOR 0.34, 95% CI 0.18-0.65, vs. subtype B) was negatively associated with late HIV diagnosis.

conclusionsIn addition to demographic factors, HCV co-infection, HIV-1 subtypes/CRFs and not belonging to a cluster were independently associated with late HIV diagnosis in Japan. These results imply the need for public health programmes aimed at the general population, including but not limited to key populations, to encourage HIV testing.

Indexed as

Hepatitis CHIV-1HIV InfectionsSexual and Gender MinoritiesCluster AnalysisDemographyEast Asian PeopleHepacivirusHomosexuality, MaleHumansMalePhylogenyRetrospective StudiesCD4 countshepatitis CHIVJapanlate diagnosisphylogenetic clustering

Identifiers

PMID37221951
PMCPMC10206413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.